Affiliations: [a] Nanjing Medical University Affiliated Lianyungang Clinical College, Department of Thoracic Surgery, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China | [b] Nanjing Medical University Affiliated Lianyungang Clinical College, Department of Oncology, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu, China
Correspondence:
[*]
Corresponding author: Jianhua Dai, Nanjing Medical University Affiliated Lianyungang Clinical College, Department of Thoracic Surgery, The First People’s Hospital of Lianyungang City, No. 182, Tongguan Road, Lianyungang, Jiangsu 222002, China. Tel.: +86 18961326450; E-mail: daijianhualyg@hotmail.com.
Note: [1] These authors contributed equally to this work.
Abstract: BACKGROUND: It is well known that some circulating microRNAs (miRNAs) are highly stable and might serve as promising biomarkers for many types of human cancer including esophageal squamous cell carcinoma (ESCC). However, the potential clinical significance of serum miR-1290 in ESCC remained unknown. OBJECTIVE: The aim of this study was to investigate the diagnostic and prognostic value of serum miR-1290 for ESCC. METHODS: The expression levels of serum miRNA-1290 in patients with ESCC and healthy controls were detected, and their potential diagnostic and prognostic value was analyzed. RESULTS: Our results showed that tissue and serum miR-1290 levels were both significantly elevated in ESCC compared to their respective controls. Tissue miR-1290 levels were highly correlated with serum miR-1290 levels. High serum miR-1290 levels were significantly associated with worse clinicopathological characteristics. Patients with high serum miR-1290 levels had significantly worse survival. Further multivariate analysis showed that serum miR-1290 was an independent risk factor for ESCC. Serum miR-1290 could effectively discriminate ESCC cases from normal controls. CONCLUSIONS: The level of serum microRNA-1290 in ESCC patients increased significantly, and its expression level could reflect the progress of ESCC, suggesting that serum microRNA-1290 might be a useful diagnostic and prognostic marker of ESCC.
